Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 8 October 2017
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 8 October 2017. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(continuation news of BXPHARMA): It is expected that the Proposed Acquisition will be completed by the end of December 2017 and will, if completed, accelerate revenue growth and improve the earning potential for Beximco Pharma. The Company has further informed that Nuvista Pharma Ltd, formerly Organon (Bangladesh) Ltd., was a subsidiary of Netherlands based Organon International. It was sold out to the current Bangladeshi Management in 2006. The Company has been operating in Bangladesh since 1964 (cont. 2)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005e8b4
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.